|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 05-20 | BioRegenx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-15 | BioRegenx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 5.34M 4.6M 4.33M 3.95M 7.39M 505M 7.41M 51.12M 19.84M 259M 20.07M 19.63M 834M | P/E 2024 |
-0.37x | P/E 2025 | -8.02x |
|---|---|---|---|---|---|
| Enterprise Value | 7.49M 6.44M 6.06M 5.54M 10.36M 707M 10.39M 71.64M 27.8M 363M 28.12M 27.51M 1.17B | EV / Sales 2024 |
4.58x | EV / Sales 2025 | 7.85x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
William Resides
CEO | Chief Executive Officer | 57 | 07/03/2024 |
Gary Hennerberg
SEC | Corporate Secretary | 69 | 07/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Powers
BRD | Director/Board Member | 71 | 31/12/2011 |
William Resides
BRD | Director/Board Member | 57 | 07/03/2024 |
Suzanne Bird
BRD | Director/Board Member | 61 | 07/03/2024 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.34M 2.01M 1.89M 1.73M 3.24M 221M 3.25M 22.39M 8.69M 113M 8.79M 8.6M 365M | 1.85M 1.6M 1.5M 1.37M 2.57M 175M 2.57M 17.74M 6.88M 89.84M 6.96M 6.81M 289M |
| Net income | -23.05M -19.84M -18.66M -17.05M -31.9M -2.18B -31.98M -221M -85.59M -1.12B -86.57M -84.68M -3.6B | -1.54M -1.33M -1.25M -1.14M -2.14M -146M -2.14M -14.77M -5.73M -74.77M -5.8M -5.67M -241M |
| Net Debt | 2.11M 1.81M 1.7M 1.56M 2.91M 199M 2.92M 20.15M 7.82M 102M 7.91M 7.74M 329M | 2.15M 1.85M 1.74M 1.59M 2.97M 203M 2.98M 20.52M 7.96M 104M 8.06M 7.88M 335M |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















